Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 23 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Hutcheon JA, Chiolero A, Hanley JA. Random measurement error and regression dilution bias. BMJ 2010;340:1402-6. [Ref.ID 88747]
2.Tiene citas relacionadas Cita con resumen
Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, for the ECASS ATLANTIS NINDS and EPITHET rt-PA Study Group Investigators. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-703. [Ref.ID 88503]
3.Tiene citas relacionadas Cita con resumen
Saver JL, Levine SR. Alteplase for ischaemic stroke - much sooner is much better. Lancet 2010;375:1667-8. [Ref.ID 88500]
4.Tiene citas relacionadas
Brotman DJ, Streiff MB. Thrombolytic therapy and mortality in patients with acute pulmonary embolism. Invited commentary. Arch Intern Med 2008;168:2191-2. [Ref.ID 84496]
5.Tiene citas relacionadas
Ibrahim SA, Stone RA, Obrosky DS, Geng M, Fine MJ, Aujesky D. Thrombolytic therapy and mortality in patients with acute pulmonary embolism. Arch Intern Med 2008;168:2183-90. [Ref.ID 84495]
6. Cita con resumen
Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH. Systematic differences in treatment effect estimates between propensity score methods and logistic regression. Int J Epidemiol 2008;37:1142-7. [Ref.ID 84293]
7.
Mould DR, Baumann A, Kuhlmann J, Keating MJ, Weitman S, Hillmen P, Brettman LR, Reif S, Bonate PL. Population pharmacokinetics-pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment response. Br J Clin Pharmacol 2007;64:278-91. [Ref.ID 80930]
8.Tiene citas relacionadas Cita con resumen
D'Agostino Jr RB, D'Agostino Sr RB. Estimating treatment effects using observational data. JAMA 2007;297:314-6. [Ref.ID 78932]
10. Cita con resumen
11.Tiene citas relacionadas Cita con resumen
Brotman DJ. Observational versus randomised trial evidence. Authors' reply. Lancet 2004;364:757. [Ref.ID 71215]
12.Tiene citas relacionadas Cita con resumen
Vandenbroucke JP. When are observational studies as credible as randomised trials?. Lancet 2004;363:1728-31. [Ref.ID 70182]
13.Tiene citas relacionadas Cita con resumen
Concato J, Horwitz RI. Beyond randomised versus observational studies. Lancet 2004;363:1660-1. [Ref.ID 70170]
14.
Katz MH. Multivariable analysis: a primer for readers of medical research. Ann Intern Med 2003;138:644-50. [Ref.ID 65731]
15. Cita con resumen
McPherson K. Epidemiology on trial - confessions of an expert witness. Lancet 2002;360:889-90. [Ref.ID 63289]
16. Cita con resumen
Ortega Calvo M, Cayuela Domínguez A. Regresión logística no condicionada y tamaño de muestra: una revisión bibliográfica. Rev Esp Salud Pública 2002;76:85-93. [Ref.ID 61628]
17.
Figueiras A, Cadarso-Suárez C. Application of nonparametric models for calculating odds ratios and their confidence intervals for continuous exposures. Am J Epidemiol 2001;154:264-75. [Ref.ID 57832]
18.
Hsieh FY, Lavori PW. Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates. Control Clin Trial 2000;21:552-60. [Ref.ID 54189]
19.
Berkey CS, Hoaglin DC, Antczak-Bouckoms A, Mosteller F, Colditz GA. Meta-analysis of multiple outcomes by regression with random effects. Stat Med 1998;17:2537-50. [Ref.ID 41464]
20.
Bender R, Grouven U. Logistic regression models used in medical research are poorly presented. BMJ 1996;313:628. [Ref.ID 29026]
Seleccionar todas
 
 1 a 20 de 23 siguiente >>